Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01013129 · ClinicalTrials.gov registry record
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
A clinical trial, sponsored by Portland VA Medical Center.
- Completed
- Registry status
- 748
- Enrollment target
NCT01013129: Completed study, sponsored by Portland VA Medical Center.
NCT01013129 is a clinical trial that has completed, run by Portland VA Medical Center. The registered enrollment target is 748 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01013129 has completed, sponsored by Portland VA Medical Center.
- COMPLETED
- Registry status
- 748 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about genetic and environmental factors may help doctors learn more about a person's risk for developing prostate cancer. PURPOSE: This research project is studying genes, environment, and prostate cancer risk in patients with or without prostate cancer.
Primary Outcome
Using saliva samples, we conducted analysis on probands' oxidative stress pathway genes and whether these were associated with prostate cancer risk.
Interventions
- OTHER laboratory biomarker analysis
- OTHER medical chart review
- OTHER questionnaire administration
- GENETIC DNA analysis
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 748 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-12 |
What the finished NCT01013129 record still lists
NCT01013129 is an observational study that tracks outcomes without assigning an intervention. The registered 748 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT01013129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01013129 about?
NCT01013129 is a clinical study titled "Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer". RATIONALE: Gathering information about genetic and environmental factors may help doctors learn more about a person's risk for developing prostate cancer. PURPOSE: This research project is studying genes, environment, and prostate cancer risk in patients with or without prostate cancer.
What is the current status of trial NCT01013129?
This trial is currently completed. The enrollment target is 748 participants. The study started on 2008-07. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01013129?
The interventions under investigation include: laboratory biomarker analysis (OTHER), medical chart review (OTHER), questionnaire administration (OTHER), DNA analysis (GENETIC), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT01013129?
This trial is sponsored by Portland VA Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia